skip to content »

Translational Biology & Molecular Medicine

Houston, Texas

Benchtop, Research, Bedside and Application
Translational Biology & Molecular Medicine Graduate Program
not shown on screen

Michael M. Ittmann, M.D., Ph.D.

Michael M. Ittmann

Professor
Department of Pathology and Immunology

Phone: 713-798-6196
E-mail: mittmann@bcm.edu
Lab Web Site: Michael Ittmann Laboratory

Education

  • Ph.D., Case Western Reserve University
  • M.D., Case Western Reserve University

Research Interests

  • Molecular genetics of prostate cancer
  • Fibroblast growth factors
  • BPH

Selected Publications

  • Castro P, Giri D, Lamb D, Ittmann M. Cellular senescence in the pathogenesis of benign prostatic hyperplasia. The Prostate. 2003. 55:30-8.
  • Ozen M, Giri D, Ropiquet F, Mansukhani A, Ittmann M. Role of fibroblast growth factor receptor signaling in prostate cancer cell survival. J Natl Canc Instit. 2001. 93:1783-90.
  • Giri D, Ittmann M. IL-1a is a paracrine inducer of FGF-7, a key epithelial growth factor in benign prostatic hyperplasia. Am J Pathol. 2000. 157:249-55.
  • Ropiquet F, Giri D, Kwabi-Addo B, Mansukhani A, Ittmann M. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. Cancer Res. 2000. 60:4245-50.
  • Giri D, Ropiquet F, Ittmann M. Alterations in expression of FGF2 and its receptor FGFR-1 in human prostate cancer. Clin Canc Res. 1999. 5:1063-71.
  • Ropiquet F, Giri D, Lamb D, Ittmann M. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. J Urol. 1999. 162:595-9.

E-mail this page to a friend